Andrew Reardon - 23 Jun 2025 Form 4 Insider Report for LIGAND PHARMACEUTICALS INC (LGND)

Signature
/s/ Andrew Reardon
Issuer symbol
LGND
Transactions as of
23 Jun 2025
Net transactions value
-$57,042
Form type
4
Filing time
24 Jun 2025, 20:29:59 UTC
Previous filing
12 Jun 2025
Next filing
02 Jul 2025

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Reardon Andrew CLO & Secretary 555 HERITAGE DRIVE, SUITE 200, JUPITER /s/ Andrew Reardon 24 Jun 2025 0001950232

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction LGND Common Stock Sale $57,042 -500 -1.5% $114.08 31,903 23 Jun 2025 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.